Philippe Armand

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 5%percentile

0.518Author DataRank

Indexed papers

2in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Five-year follow-up of a phase 2 study of ibrutinib plus fludarabine, cyclophosphamide, and rituximab as initial therapy in CLL

Blood Advances(2024)10.1182/bloodadvances.2023011574

Top 37%

0.518DataRank

Top 37%12 citations

Danielle M. Brander, Yue Ren, Yinglu Zhou, Svitlana Tyekucheva, Heather A. Walker +18 more

Papers

Driven by 20 papers — median percentile 63. Top paper: “Acalabrutinib, venetoclax, and obinutuzumab as frontline treatment for chronic lymphocytic leukaemia: a single-arm, open-label, phase 2 study”.

Acalabrutinib, venetoclax, and obinutuzumab as frontline treatment for chronic lymphocytic leukaemia: a single-arm, open-label, phase 2 study

The Lancet Oncology(2021)10.1016/s1470-2045(21)00455-1

N/A

3.3DataRank · unranked

104 citations

Benjamin L. Lampson, Svitlana Tyekucheva, Zixu Wang, Jessica Lowney, Samantha Pazienza +13 more

A multicenter phase 1 study of nivolumab for relapsed hematologic malignancies after allogeneic transplantation

Blood(2020)10.1182/blood.2019004710

N/A

2.8DataRank · unranked

99 citations

Haesook T. Kim, Caitlin Costello, Alex F. Herrera, Frederick L. Locke, Rodrigo Maegawa +20 more

PD-1 blockade for diffuse large B-cell lymphoma after autologous stem cell transplantation

Blood Advances(2020)10.1182/bloodadvances.2019000784

N/A

2.0DataRank · unranked

65 citations

Philippe Armand, Robert Redd, Erin Jeter, Reid W. Merryman, Kimberly C. Coleman +21 more

Spatial signatures identify immune escape via PD-1 as a defining feature of T-cell/histiocyte-rich large B-cell lymphoma

Blood(2020)10.1182/blood.2020006464

N/A

1.9DataRank · unranked

59 citations

Jason L. Weirather, Margaretha G.M. Roemer, Mikel Lipschitz, Alyssa Kelley, Pei-Hsuan Chen +26 more

Baseline immune state and T-cell clonal kinetics are associated with durable response to CAR-T therapy in large B-cell lymphoma

Blood(2024)10.1182/blood.2024024381

N/A

0.840DataRank · unranked

19 citations

Isabella N. Grabski, Roch Houot, Satyen H. Gohil, Shogo Miura, Robert Redd +19 more

Sodium-Glucose Co-Transporter-2 Inhibitors and Cardiac Outcomes Among Patients Treated With Anthracyclines

JACC Heart Failure(2022)10.1016/j.jchf.2022.03.006

N/A

0.759DataRank · unranked

157 citations

Zsófia D. Drobni, Thiago Quinaglia Araujo Costa Silva, Amna Zafar, Jingyi Gong, Daniel A. Zlotoff +14 more

Immune Reconstitution following High-Dose Chemotherapy and Autologous Stem Cell Transplantation with or without Pembrolizumab Maintenance Therapy in Patients with Lymphoma

Transplantation and Cellular Therapy(2021)10.1016/j.jtct.2021.10.010

N/A

0.618DataRank · unranked

17 citations

Robert Redd, Erin Jeter, Jeff L. Wong, Kristin M McHugh, Carol Reynolds +21 more

A phase 2 study of pembrolizumab after autologous stem cell transplantation in patients with T-cell non-Hodgkin lymphoma

Blood(2023)10.1182/blood.2023020244

N/A

0.598DataRank · unranked

15 citations

Parastoo B. Dahi, Robert Redd, Mikaela M. McDonough, Yi‐Bin Chen, Zachariah DeFilipp +15 more

Molecular and cellular features of CTLA-4 blockade for relapsed myeloid malignancies after transplantation

Blood(2021)10.1182/blood.2021010867

N/A

0.564DataRank · unranked

42 citations

Yi Zhang, Alexandra Savell, Teddy Huang, Nicoletta Cieri, Emily M. Thrash +33 more

Frontline management of mantle cell lymphoma

Blood(2025)10.1182/blood.2023022352

N/A

0.529DataRank · unranked

33 citations

Philippe Armand, Ann S. LaCasce, Christine E. Ryan

Five-year follow-up of a phase 2 study of ibrutinib plus fludarabine, cyclophosphamide, and rituximab as initial therapy in CLL

Blood Advances(2024)10.1182/bloodadvances.2023011574

Top 37%

0.518DataRank

Top 37%12 citations

Danielle M. Brander, Yue Ren, Yinglu Zhou, Svitlana Tyekucheva, Heather A. Walker +18 more

A T cell inflammatory phenotype is associated with autoimmune toxicity of the PI3K inhibitor duvelisib in chronic lymphocytic leukemia

Leukemia(2021)10.1038/s41375-021-01441-9

N/A

0.464DataRank · unranked

21 citations

Alec Griffith, Svitlana Tyekucheva, Zixu Wang, Vanessa Rai, Alexander R. Vartanov +14 more

Characteristics and outcomes of patients with double refractory and double exposed chronic lymphocytic leukemia

Blood Advances(2025)10.1182/bloodadvances.2025016006

N/A

0.385DataRank · unranked

12 citations

Yinglu Zhou, Mariia Mikhaleva, Daniel Choi, Stacey M. Fernandes, Philippe Armand +20 more

Circulating Th17 T cells at treatment onset predict autoimmune toxicity of PI3Kδ inhibitors

Blood Cancer Journal(2023)10.1038/s41408-023-00788-9

N/A

0.208DataRank · unranked

3 citations

Stephen P. Martindale, Pui Yan Chiu, Jasneet Kaur Khalsa, Pei-Hsuan Chen, Stacey M. Fernandes +10 more

SAVE (Safe Accelerated Venetoclax Escalation): Initial results of a prospective, phase Ib study of venetoclax with an accelerated dose ramp-up in patients with CLL.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.7512

N/A

0.165DataRank · unranked

2 citations

Inhye E. Ahn, Svitlana Tyekucheva, Reid W. Merryman, David C. Fisher, Philippe Armand +7 more

Allogeneic transplantation after PD-1 blockade for classic Hodgkin lymphoma

Leukemia(2021)10.1038/s41375-021-01193-6

N/A

0DataRank · unranked

83 citations

Luca Castagna, Laura Giordano, Vincent T. Ho, Paolo Corradini, Anna Guidetti +61 more

Impact of sodium-glucose cotransporter-2 inhibitors on heart failure and mortality in patients with cancer

Heart(2022)10.1136/heartjnl-2022-321545

N/A

0DataRank · unranked

61 citations

Cho‐Hung Chiang, Cho‐Hsien Chiang, Kevin Sheng‐Kai, Chun-Yu Peng, Yuan Ping Hsia +14 more

Data from Phase II Study of Dasatinib in Relapsed or Refractory Chronic Lymphocytic Leukemia

(2023)10.1158/1078-0432.c.6518805.v1

N/A

0DataRank · unranked

0 citations

Eyal C. Attar, Tak Takvorian, Ephraim P. Hochberg, Karen K. Ballen, K. Leahy +9 more

Consensus recommendations from the 2024 International Follicular Lymphoma Scientific Workshop

Blood Advances(2025)10.1182/bloodadvances.2025018079

N/A

0DataRank · unranked

3 citations

Sarah C. Rutherford, Stephen M. Ansell, Philippe Armand, John P. Leonard, Loretta J. Nastoupil +20 more

Clinical efficacy and safety of chimeric antigen receptor T‐cell therapy for mantle cell lymphoma with secondary central nervous system involvement

British Journal of Haematology(2023)10.1111/bjh.19037

N/A

0DataRank · unranked

16 citations

Rebecca L. Zon, Robert Redd, David C. Fisher, Roni Shouval, Anita Kumar +12 more

Philippe Armand

Indexed papers

Top data-sharing exemplar

Papers